LONDON, Oct. 11, 2013 /CNW/ - HemoCue America, a global leader in
advanced point-of-care testing (POCT) systems, announced on October 9,
2013 that the American Red Cross, the world's largest blood bank
organization, has signed a five-year agreement on instruments and
consumables for hemoglobin testing of blood donors.
To view the Multimedia News Release, please click:
HemoCue has served ARC with lab accurate tests for pre-donation
hemoglobin testing since 2006 and the new agreement is an extension of
this service including upgrading to a new product platform.
Peter Troija, Executive Director of HemoCue America states, "I am
honored and excited to have signed this important and prestigious
contract with the American Red Cross."
"This order underlines the strong relationship and trust HemoCue and the
American Red Cross have developed over the years," says Niels
Christiansen President of HemoCue. "ARC has renewed its confidence in
our products and services, and we are happy to continue to work
together withARC helping to meet the need for blood while protecting
the source - the donors - by providing lab accurate hemoglobin tests."
Over the years, HemoCue has been setting the standard for hemoglobin
point-of-care testing. This standard enables an immediate result of the
hemoglobin test at the point of care, with the same accuracy as if
analyzed at a central lab. Today, HemoCue has earned the trust to
supply hemoglobin tests to blood banks and other healthcare settings in
more than 130 countries worldwide.
HemoCue invented and introduced the lab-accurate method to measure
hemoglobin at the point of care in the '80s. Since then, several
product generations have been developed to constantly improve the
performance and meet customers' expectations. Today, the product
portfolio ranges from standalone instruments aimed for extreme climates
and short measurement time, to fully equipped data management systems
for integration in hospitals lab information systems and medical
records, as well as dedicated systems for measuring low levels of free
hemoglobin in blood and other liquids.
HemoCue, acquired by Radiometer ApS in April 2013, is a global leader in
point-of-care testing. HemoCue AB (Ängelholm, Sweden), introduced in
1982 the first accurate, near-patient hemoglobin test. The company also
sells point-of-care tests for glucose, urine albumin, HbA1c, total and
differential white blood cell count.
SOURCE: HemoCue AB
For further information:
Niels Christiansen, President